Frontlight ResearchEarly access
Trial site
Hospital de Cancer de Londrina
- 9running trials
- 1closed trial
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Lung cancer4 trials
- Metastatic breast cancer3 trials
- Bladder cancer1 trial
- Childhood cancers1 trial
- Kidney cancer1 trial
- Liver and biliary tract cancer1 trial
- Melanoma1 trial
- Prostate cancer1 trial
- Thyroid cancer1 trial
- Phase
- Phase 39 trials
- Phase 21 trial
- Status
- Active, not recruiting4 trials
- Recruiting4 trials
- Not yet recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Eli Lilly and Company7 trials
- Incyte Corporation1 trial
- Loxo Oncology, Inc.1 trial
- Pfizer1 trial
Running trials
Recruiting
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer2 recruiting
- Metastatic breast cancer2 recruiting
- Bladder cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 18 Nov 2026